These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 7194062

  • 1. [Therapeutic experiences in the treatment of hyperlipoproteinaemia with etofylline clofibrate (author's transl)].
    Vorberg G, Ziegler WJ.
    Arzneimittelforschung; 1980; 30(11b):2068-72. PubMed ID: 7194062
    [Abstract] [Full Text] [Related]

  • 2. [Clinical effects and tolerance of etofylline clofibrate].
    Ziegler WJ, Metz G, Specker M.
    Arzneimittelforschung; 1980; 30(11b):2053-8. PubMed ID: 7194059
    [Abstract] [Full Text] [Related]

  • 3. [On the effect of etofylline clofibrate on serum lipids and lipoproteins in patients with hyperlipoproteinemia of various degrees (author's transl)].
    Schneider J, Mühlfellner G, Mühlfellner O, Hausmann L, Schubotz R.
    Arzneimittelforschung; 1980; 30(11b):2059-62. PubMed ID: 7194060
    [Abstract] [Full Text] [Related]

  • 4. [Effect of etofylline clofibrate on the composition of lipoproteins in hyperlipidaemia type IIb and IV (author's transl)].
    Ditschuneit HH, Hutt V, Klör HU, Ditschuneit H.
    Arzneimittelforschung; 1980; 30(11b):2063-7. PubMed ID: 7194061
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Etofylline clofibrate in the treatment of diabetic dyslipidemia: results of a 6-month period of therapy].
    Rajecová E, Klimes I, Seböková E, Rychnavská E, Pleváková L, Linke-Cvrkalová A, Langrová H.
    Vnitr Lek; 1995 Oct; 41(10):677-81. PubMed ID: 8578698
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Biopharmaceutic evaluation of etofylline clofibrate and its drug formulation.
    Ritschel WA, Thompson GA, Lücker PW, Wetzelsberger K.
    Arzneimittelforschung; 1980 Oct; 30(11b):2020-3. PubMed ID: 7194052
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [A comparison of bezafibrate and clofibrate in type II B and type IV hyperlipoproteinemia].
    Bolzano K, Krempler F, Schellenberg B, Schlierf G.
    Acta Med Austriaca; 1979 Oct; 6(3):90-4. PubMed ID: 547652
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pirifibrate in the treatment of hyperlipoproteinemias: a multicenter study.
    Domingo AJ, Gutiérrez JA, Menéndez JA, Micó L, Muñoz M, de Oya M.
    Clin Ther; 1980 Oct; 3(3):219-26. PubMed ID: 7459931
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Chemistry of phenoxyacetic acid esters of oxyalkyltheophyllines and 1-(theophyllin-7-yl)-ethyl-2-[2-(p-chlorophenoxy)-2-methyl-propionate] (etofylline clofibrate), a novel antilipaemic agent (author's transl)].
    Metz G, Specker M.
    Arzneimittelforschung; 1980 Oct; 30(11b):2014-9. PubMed ID: 7194051
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.